Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

Apple Cider Vinegar exposes the fakeness of the virtual world where everything appears to be perfect - except it isn’t - ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...